Table 4.
Physiological/pathological indications | Significant findings | Source |
---|---|---|
Neurite outgrowth/neuronal survival | SPC interacts with GPR12 and promotes the proliferation of neuronal precursor cells and the maturation of post-mitotic neurons | Ignatov et al. [19] |
GPR12 overexpression promotes neurite outgrowth | Tanaka et al. [35] | |
GPR12 initiates neurite outgrowth in PC12 cells | Lu et al [24] | |
Obesity and metabolic disorders | GPR12 knockout mice display increased dyslipidemia and obesity | Bjursell et al. [53] |
Oocyte maturation | GPR12 overexpression in oocytes leads to meiotic arrest, whereas GPR12 downregulation allows meiotic resumption | Hinckley et al. [13] |
Cell survival and proliferation | GPR12 enhances cell proliferation and survival in HEK293 cells | Lu et al. [54] |
Cancer | GPR12 promotes keratin 8 phosphorylation and reorganization, reducing cancer cell viscoelasticity | Park et al. [56] |
GPR12 G protein-coupled receptor 12, SPC sphingosylphosphorylcholine, PC12 rat adrenal phaeochromocytoma cell line, HEK293 human embryonic kidney cell line